Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
Purpose: Epithelial cell adhesion molecule (EpCAM) is a dominant antigen in human colon carcinoma tissue. Topology features of this antigen are different in normal and malignant conditions; for instance, EpCAM is much less accessible to antibodies in normal cells than in cancerous tissues. Hence, Ep...
Main Authors: | Seyed-Ali Hosseinian, Aliakbar Haddad-Mashadrizeh, Samaneh Dolatabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2018-08-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | http://apb.tbzmed.ac.ir/PDF/apb-8-447.pdf |
Similar Items
-
Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01) -
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01) -
CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
by: Andisheh Bagheri, et al.
Published: (2022-03-01) -
Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by: Guanjie Li, et al.
Published: (2022-06-01) -
Evolution of Thyroglobulin Loop Kinetics in EpCAM
by: Serena H. Chen, et al.
Published: (2021-09-01)